Lao Lucius version of Mobosetinib (Mobosetinib) usage and purchase guide

Mobocertinib (Mobocertinib, trade name: Exkivity) is a targeted therapy for locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations. However, the original version of the drug is priced higher, making it difficult for some patients to afford it. For such patients, generic mobotinib produced by Lucius Pharmaceuticals Laos provides a cost-effective treatment option. The following is a guide to the use and purchase of Mobotinib, Lucius version in Laos.

1. Instructions for use:

Mobotinib is a prescription drug and must be used under the guidance of a doctor. Patients should fully understand the drug's mechanism of action, usage and dosage, and possible adverse reactions before use. The recommended dose of mobotinib is 160 mg once daily until disease progression or unacceptable toxicity. If the patient experiences adverse reactions, the first dose can be adjusted to 120 mg once a day under the guidance of a doctor; if the adverse reactions persist and the patient is still intolerant, the second dose can be further adjusted to 80 mg once a day. The adjustment of the treatment plan must strictly follow the doctor's instructions. Patients should take it at the same time each day, and the capsules should be swallowed whole without opening, chewing, or dissolving the capsule contents. If you miss a dose by more than 6 hours, skip the dose and take the next dose at your regular time the next day. If you vomit soon after taking this dose, do not take more and take your next dose as scheduled. Patients should not stop taking it without the advice of their attending physician.

In addition, patients should regularly monitor their physical condition and communicate with their doctors in a timely manner while using mobotinib. If you have any discomfort or questions, you should contact your doctor immediately and adjust your medication regimen according to your doctor's advice.

2. Buying Guide:

The price of the Laos Lucious version of the generic version of Mobotinib is relatively low, about more than 3,000 yuan, which reduces the financial burden on patients. However, you need to be cautious when purchasing drugs overseas. Patients must choose regular and guaranteed merchants when choosing purchase channels. It is recommended to consult and purchase through regular overseas medical service institutions to ensure the quality and authenticity of medicines. Before purchasing, patients should carefully check the packaging, labels, instructions and other information of the medicine to ensure that the medicine purchased is consistent with official information.

In short, the Laos Lucius version of mobotinib provides a new treatment option for patients with non-small cell lung cancer carryingEGFR exon 20 insertion mutations, but safety and effectiveness still need to be paid attention to during use.

References:

https://www.drugs.com/search.php?searchterm=Exkivity&sources%5B%5D=professional